⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TCRX News

TScan Therapeutics, Inc. Common Stock

TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027